Coronary IVL TCT Data By the Numbers
Consistent Over Time
Longest-term analysis of coronary IVL, Disrupt CAD III, confirms consistency of the excellent safety and effectiveness outcomes at 30 days out to one year.
Consistent Across Calcium Morphologies
Most rigorous OCT pooled analysis of any calcium modification therapy in over 250 patients showcases IVL’s ability to achieve excellent MSA and stent expansion consistently across different calcium morphologies.
Dr. Ziad Ali
St. Francis Hospital and Heart Center
Dr. Akiko Maehara
Columbia University Irving Medical Center
New York, NY
Consistent Outcomes Between Women & Men
Unlike previous findings with atherectomy1 , IVL showed consistent safety outcomes in men and women despite more frequent comorbidities and smaller vessel size in women.
Dr. Yasin Hussain
Yale-New Haven Hospital,
New Haven, CT